𝔖 Bobbio Scriptorium

✦ LIBER ✦

An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir

✍ Scribed by Marcelo M. Gutierrez; Jeffrey Rosenberg; Wattanaporn Abramowitz

Book ID: 117321384
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 539 KB
Volume: 25
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(03)80076-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytochrome P450 3A4 and P-glycoprotein m

Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin

✍ Paine, M 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

Pharmacokinetic interaction between tand

Pharmacokinetic interaction between tandospirone and fluvoxamine in the rat contextual conditioned fear stress model and its functional consequence: Involvement of cytochrome P450 3A4

✍ Hiroyuki Nishikawa; Takeshi Inoue; Takuya Masui; Takeshi Izumi; Shin Nakagawa; T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

A Mechanism-Based Pharmacokinetic Model

A Mechanism-Based Pharmacokinetic Model for the Cytochrome P450 Drug–Drug Interaction between Cyclophosphamide and ThioTEPA and the Autoinduction of Cyclophosphamide

✍ Alwin D. R. Huitema; Ron A. A. Mathôt; Matthijs M. Tibben; Sjoerd Rodenhuis; Jos 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 159 KB

A clinical study investigating the pharm

A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate

✍ Milan Zdravkovic; Anette K. Olsen; Tina Christiansen; Rainer Schulz; Mitchell E. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 236 KB

Evaluation of the potential for steady-s

Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects*

✍ Ayalasomayajula, Surya P.; Dole, Kiran; He, Yan-Ling; Ligueros-Saylan, Monica; W 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 349 KB

Effects of myricetin, an antioxidant, on

Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin

✍ Dong-Hyun Choi; Cheng Li; Jun-Shik Choi 📂 Article 📅 2010 🏛 Pharmaceutical Press 🌐 English ⚖ 222 KB